Intraperitoneal administration of quetiapine improved the paw withdrawal pressure threshold, as a sign of reduced nociception, and was correlated with lower mRNA levels of TRPV1 and TRPV4 in C3H/HeN mice with cancer pain [185]. Here, TRPV1 is linked to cancer.